NovaBridge Biosciences Ratios (2017-2025) | NBP

Ratios Dec2017 Dec2018 Sep2019 Dec2019 Jun2020 Sep2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Sep2023 Dec2023 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
100,000,000.00%
EBT Margin (Quarter)
388,849.08%-17,332.08%-2,609.84%
EBIT Margin (Quarter)
-31,714.02%-7,578.62%-3,375.87%
EBITDA Margin (Quarter)
-31,714.02%-7,578.62%-3,375.87%
Operating Margin (Quarter)
-31,714.02%-7,578.62%-3,375.87%
Net Margin (Quarter)
384,335.79%10,557.46%
FCF Margin (Quarter)
370,265.68%
Efficiency
Inventory Average (Quarter)
2.13B0.00B
Assets Average (Quarter)
0.27B0.46B0.79B0.95B0.91B0.81B0.66B0.53B0.24B0.22B0.21B0.21B0.24B0.27B
Equity Average (Quarter)
-0.09B0.70B0.85B0.78B0.66B0.50B0.37B0.23B0.21B0.20B0.20B0.23B0.24B
Invested Capital (Quarter)
-0.13B-0.28B0.55B0.85B0.85B0.71B0.61B0.41B0.35B0.24B0.24B0.22B0.20B0.20B0.20B0.26B0.23B
Leverage & Solvency
Interest Coverage Ratio (Quarter)
578.19-61.18-0.00B
Debt to Equity (Quarter)
-0.08-0.020.010.010.02
Debt Ratio (Quarter)
0.030.030.000.010.01
Equity Ratio (Quarter)
-0.40-1.170.870.890.890.810.800.710.700.660.930.940.950.950.950.930.89
Times Interest Earned (Quarter)
578.19-61.18-0.00B
Valuation
Enterprise Value (Quarter)
-0.24B-0.18B-0.17B-0.22B-0.44B-0.72B-0.80B-118.35B-0.59B-0.47B-0.42B-0.32B-0.21B-0.42B-0.17B-0.17B-0.17B-0.23B-0.21B
Return Ratios
Return on Sales (Quarter)
39.34%2.13%0.79%
Return on Capital Employed (Quarter)
12,497.49%20,235.05%-33.49%-24.01%-23.73%-19.04%-15.37%-38.94%
Return on Invested Capital (Quarter)
0.00%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%